Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Targeted genome editing in haematopoeitic stem cells

Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy
Targeted genome editing in haematopoeitic stem cells ( Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy )
11 Jun 2016

A microRNA driver of B-cell leukaemia

Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy
A microRNA driver of B-cell leukaemia ( Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy )
11 Jun 2016

Safety and efficacy of imatinib generics

Prof Tomasz Sacha - Jagiellonian University, Krakow, Poland
Safety and efficacy of imatinib generics ( Prof Tomasz Sacha - Jagiellonian University, Krakow, Poland )
11 Jun 2016

Meta-analysis of overall survival in multiple myeloma treated with lenalidomide

Dr Philip McCarthy - Roswell Park Cancer Institute, New York, USA
Meta-analysis of overall survival in multiple myeloma treated with lenalidomide ( Dr Philip McCarthy - Roswell Park Cancer Institute, New York, USA )
11 Jun 2016

Clinical characteristics and prognostic factors of plasmablastic lymphoma patients

Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients ( Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France )
11 Jun 2016

Blinatumomab improves survival of relapsed B-cell leukaemia

Prof Max Topp - University of Würzburg, Würzburg, Germany
Blinatumomab improves survival of relapsed B-cell leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
11 Jun 2016

Multiple myeloma highlights from EHA 2016

Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Paul Richardson, Prof Philip McCarthy
Multiple myeloma highlights from EHA 2016 ( Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Paul Richardson, Prof Philip McCarthy )
10 Jun 2016

Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia

Dr Charles De Bock - KU Leuven, Leuven, Belgium
Activated JAK-STAT signaling co-operates with HOXA9 to drive leukaemia ( Dr Charles De Bock - KU Leuven, Leuven, Belgium )
10 Jun 2016

SL401 in patients with rare neoplasm

Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center, Houston, United States
SL401 in patients with rare neoplasm ( Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center, Houston, United States )
10 Jun 2016

RNA regulation of JAK-STAT pathways in CML

Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA
RNA regulation of JAK-STAT pathways in CML ( Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA )
10 Jun 2016

The value and strategy for incorporating biosimilars Into clinical practice

Dr Francisco Esteva - New York University, New York, USA
The value and strategy for incorporating biosimilars Into clinical practice ( Dr Francisco Esteva - New York University, New York, USA )
7 Jun 2016

Checkpoint inhibitor therapy benefits advanced bladder cancer patients

Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA
Checkpoint inhibitor therapy benefits advanced bladder cancer patients ( Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA )
7 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation